Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery
2023 · Molecular Therapy · 41 citations
https://doi.org/10.1016/j.ymthe.2023.07.020
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
127
Citations
4
h-index
4
i10-index
Kelley Penraat is an academic researcher from Novartis (United States). The author has contributed to research in topics: Virus-based gene therapy research & RNA Research and Splicing & RNA Interference and Gene Delivery. The author has an h-index of 4, co-authored 7 publications.
ORCID: 0000-0003-1689-3053https://doi.org/10.1016/j.ymthe.2023.07.020
https://doi.org/10.1177/01926233241311277
Click to start Chat